Colrain Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.74M | Sell |
124,000
-9,000
| -7% | -$417K | 4.43% | 9 |
|
|
2025
Q1 | $8.11M | Buy |
133,000
+11,500
| +9% | +$701K | 6.93% | 5 |
|
|
2024
Q4 | $6.87M | Buy |
+121,500
| New | +$6.87M | 6.74% | 5 |
|
|
2014
Q1 | – | Sell |
-1,000
| Closed | -$53K | – | 109 |
|
|
2013
Q4 | $53K | Sell |
1,000
-1,500
| -60% | -$79.5K | ﹤0.01% | 102 |
|
|
2013
Q3 | $116K | Sell |
2,500
-1,000
| -29% | -$46.4K | 0.01% | 98 |
|
|
2013
Q2 | $156K | Buy |
+3,500
| New | +$156K | 0.01% | 95 |
|